Attention-deficit hyperactivity disorder, its treatment with medication and the probability of developing a depressive disorder: A nationwide population-based study in Taiwan

Journal of Affective Disorders

Volumn 189, Issue , 2016, Pages 110-117

  Lee, Min Jing ^a   Yang, Kang Chung ^b,c   Shyu, Yu Chiau ^d,e   Yuan, Shin Sheng ^c   Yang, Chun Ju ^d,f   Lee, Sheng Yu ^g,h   Lee, Tung Liang ⁱ   Wang, Liang Jen ^a  

^a CHANG GUNG UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^c INSTITUTE OF STATISTICAL SCIENCE   (Taiwan)

^d CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^e INSTITUTE OF MOLECULAR BIOLOGY   (Taiwan)

^f NATIONAL YANG MING UNIVERSITY   (Taiwan)

^g KAOHSIUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^h NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

ⁱ UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

ADHD; Comorbidity; Epidemiology; Mood disorders; Stimulant

Indexed keywords

ATOMOXETINE; METHYLPHENIDATE;

ARTICLE; ATTENTION DEFICIT DISORDER; CHILD; COMORBIDITY; DATA BASE; DEPRESSION; DYSTHYMIA; FEMALE; HIGH RISK PATIENT; HUMAN; LONG TERM CARE; MAJOR DEPRESSION; MALE; POPULATION RESEARCH; PRIORITY JOURNAL; PROBABILITY; TAIWAN; TREATMENT DURATION; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CHEMICALLY INDUCED; DEPRESSIVE DISORDER; RETROSPECTIVE STUDY;

ATOMOXETINE HYDROCHLORIDE; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CHILD; COMORBIDITY; DEPRESSIVE DISORDER; FEMALE; HUMANS; MALE; METHYLPHENIDATE; PROBABILITY; RETROSPECTIVE STUDIES; TAIWAN;

EID: 84943402236     PISSN: 01650327     EISSN: 15732517     Source Type: Journal    
DOI: 10.1016/j.jad.2015.09.015     Document Type: Article

References (51)

1. C. Allgulander, and L.D. Fisher Survival analysis (or time to an event analysis), and the Cox regression model - methods for longitudinal psychiatric research Acta Psychiatr. Scand. 74 1986 529 535
2. A.F. Arnsten, and K. Rubia Neurobiological circuits regulating attention, cognitive control, motivation, and emotion: disruptions in neurodevelopmental psychiatric disorders J. Am. Acad. Child Adolesc. Psychiatry 51 2012 356 367
3. P. Atzori, T. Usala, S. Carucci, F. Danjou, and A. Zuddas Predictive factors for persistent use and compliance of immediate-release methylphenidate: a 36-month naturalistic study J. Child Adolesc. Psychopharmacol. 19 2009 673 681
4. S.P. Becker, A.M. Luebbe, and J.M. Langberg Co-occurring mental health problems and peer functioning among youth with attention-deficit/hyperactivity disorder: a review and recommendations for future research Clin. Child Family Psychol. Rev. 15 2012 279 302
5. J. Biederman, S.W. Ball, M.C. Monuteaux, E. Mick, T.J. Spencer, M. McCreary, M. Cote, and S.V. Faraone New insights into the comorbidity between ADHD and major depression in adolescent and young adult females J. Am. Acad. Child Adolesc. Psychiatry 47 2008 426 434
6. J. Biederman, and S.V. Faraone Attention-deficit hyperactivity disorder Lancet 366 2005 237 248
7. J. Biederman, M.C. Monuteaux, T. Spencer, T.E. Wilens, and S.V. Faraone Do stimulants protect against psychiatric disorders in youth with ADHD? A 10-year follow-up study Pediatrics 124 2009 71 78
8. J. Biederman, C.R. Petty, C. Dolan, S. Hughes, E. Mick, M.C. Monuteaux, and S.V. Faraone The long-term longitudinal course of oppositional defiant disorder and conduct disorder in ADHD boys: findings from a controlled 10-year prospective longitudinal follow-up study Psychol. Med. 38 2008 1027 1036
9. J. Biederman, J. Wozniak, L. Tarko, G. Serra, M. Hernandez, K. McDermott, K.Y. Woodsworth, M. Uchida, and S.V. Faraone Re-examining the risk for switch from unipolar to bipolar major depressive disorder in youth with ADHD: a long term prospective longitudinal controlled study J. Affect. Disord. 152-154 2014 347 351
10. B.R. Brookshire, and S.R. Jones Chronic methylphenidate administration in mice produces depressive-like behaviors and altered responses to fluoxetine Synapse 66 2012 844 847
11. W.A. Carlezon Jr., S.D. Mague, and S.L. Andersen Enduring behavioral effects of early exposure to methylphenidate in rats Biol. Psychiatry 54 2003 1330 1337
12. M.H. Chen, Y.S. Chen, J.W. Hsu, K.L. Huang, C.T. Li, W.C. Lin, W.H. Chang, T.J. Chen, T.L. Pan, T.P. Su, and Y.M. Bai Comorbidity of ADHD and subsequent bipolar disorder among adolescents and young adults with major depression: a nationwide longitudinal study Bipolar Disord. 2014
13. M.H. Chen, T.P. Su, Y.S. Chen, J.W. Hsu, K.L. Huang, W.H. Chang, T.J. Chen, and Y.M. Bai Higher risk of developing mood disorders among adolescents with comorbidity of attention deficit hyperactivity disorder and disruptive behavior disorder: a nationwide prospective study J. Psychiatr. Res. 47 2013 1019 1023
14. J.Y. Cheng, R.Y. Chen, J.S. Ko, and E.M. Ng Efficacy and safety of atomoxetine for attention-deficit/hyperactivity disorder in children and adolescents-meta-analysis and meta-regression analysis Psychopharmacology (Berlin) 194 2007 197 209
15. A. Chronis-Tuscano, B.S. Molina, W.E. Pelham, B. Applegate, A. Dahlke, M. Overmyer, and B.B. Lahey Very early predictors of adolescent depression and suicide attempts in children with attention-deficit/hyperactivity disorder Arch. Gen. Psychiatry 67 2010 1044 1051
16. W.B. Daviss A review of co-morbid depression in pediatric ADHD: etiology, phenomenology, and treatment J. Child Adolesc. Psychopharmacol. 18 2008 565 571
17. W.B. Daviss, B. Birmaher, R.S. Diler, and J. Mintz Does pharmacotherapy for attention-deficit/hyperactivity disorder predict risk of later major depression? J. Child Adolesc. Psychopharmacol. 18 2008 257 264
18. W.B. Daviss, and R. Diler Does comorbid depression predict subsequent adverse life events in youth with attention-deficit/hyperactivity disorders? J. Child Adolesc. Psychopharmacol. 22 2012 65 71
19. B. Dell'Osso, M.C. Palazzo, L. Oldani, and A.C. Altamura The noradrenergic action in antidepressant treatments: pharmacological and clinical aspects CNS Neurosci. Ther. 17 2011 723 732
20. M. Di Trani, F. Di Roma, E. Andriola, D. Leone, P. Parisi, S. Miano, and R. Donfrancesco Comorbid depressive disorders in ADHD: the role of ADHD severity, subtypes and familial psychiatric disorders Psychiatry Investig. 11 2014 137 142
21. R.S. Diler, W.B. Daviss, A. Lopez, D. Axelson, S. Iyengar, and B. Birmaher Differentiating major depressive disorder in youths with attention deficit hyperactivity disorder J. Affect. Disord. 102 2007 125 130
22. Y.S. Ding, M. Naganawa, J.D. Gallezot, N. Nabulsi, S.F. Lin, J. Ropchan, D. Weinzimmer, T.J. McCarthy, R.E. Carson, Y. Huang, and M. Laruelle Clinical doses of atomoxetine significantly occupy both norepinephrine and serotonin transports: implications on treatment of depression and ADHD Neuroimage 86 2014 164 171
23. K. Gajria, M. Lu, V. Sikirica, P. Greven, Y. Zhong, P. Qin, and J. Xie Adherence, persistence, and medication discontinuation in patients with attentiondeficit/hyperactivity disorder-a systematic literature review Neuropsychiatr. Dis. Treat. 10 2014 1543 1569
24. S.S. Gau, M.Y. Chong, T.H. Chen, and A.T. Cheng A 3-year panel study of mental disorders among adolescents in Taiwan Am. J. Psychiatry 162 2005 1344 1350
25. P. Golubchik, A. Kodesh, and A. Weizman Attention-deficit/hyperactivity disorder and comorbid subsyndromal depression: what is the impact of methylphenidate on mood? Clin. Neuropharmacol. 36 2013 141 145
26. P. Hammerness, K. McCarthy, E. Mancuso, C. Gendron, and D. Geller Atomoxetine for the treatment of attention-deficit/hyperactivity disorder in children and adolescents: a review Neuropsychiatr. Dis. Treat. 5 2009 215 226
27. K. Hawton, K. Saunders, A. Topiwala, and C. Haw Psychiatric disorders in patients presenting to hospital following self-harm: a systematic review J. Affect. Disord. 151 2013 821 830
28. J. Hesson, and K. Fowler Prevalence and correlates of self-reported ADD/ADHD in a large national sample of Canadian adults J. Atten. Disord. 2015
29. T. Inoue, Y. Inagaki, T. Kimura, and O. Shirakawa Prevalence and predictors of bipolar disorders in patients with a major depressive episode: the Japanese epidemiological trial with latest measure of bipolar disorder (JET-LMBP) J. Affect. Disord. 174 2015 535 541
30. J.M. Jerrell, R.S. McIntyre, and Y.M. Park Risk factors for incident major depressive disorder in children and adolescents with attention-deficit/hyperactivity disorder Eur. Child Adolesc. Psychiatry 24 2015 65 73
31. R.G. Klein, S. Mannuzza, M.A. Olazagasti, E. Roizen, J.A. Hutchison, E.C. Lashua, and F.X. Castellanos Clinical and functional outcome of childhood attention-deficit/hyperactivity disorder 33 years later Arch. Gen. Psychiatry 69 2012 1295 1303
32. A. Lakic Depressive symptoms as a side effect of the sustained release form of methylphenidate in a 7-year-old boy with attention-deficit hyperactivity disorder Vojnosanit. Pregl. 69 2012 201 204
33. R.S. McIntyre, S.H. Kennedy, J.K. Soczynska, H.T. Nguyen, T.S. Bilkey, H.O. Woldeyohannes, J.A. Nathanson, S. Joshi, J.S. Cheng, K.M. Benson, and D.J. Muzina Attention-deficit/hyperactivity disorder in adults with bipolar disorder or major depressive disorder: results from the international mood disorders collaborative project Prim. Care Companion J. Clin. Psychiatry 2010 12
34. M.C. Meinzer, J.W. Pettit, and C. Viswesvaran The co-occurrence of attention-deficit/hyperactivity disorder and unipolar depression in children and adolescents: a meta-analytic review Clin. Psychol. Rev. 34 2014 595 607
35. G. Parker, and K. Roy Adolescent depression: a review Aust. N. Z. J. Psychiatry 35 2001 572 580
36. S.R. Pliszka Comorbidity of attention-deficit/hyperactivity disorder with psychiatric disorder: an overview J. Clin. Psychiatry 59 Suppl. 7 1998 S50 S58
37. M.F. Rabito-Alcon, and J. Correas-Lauffer Treatment guidelines for attention deficit and hyperactivity disorder: a critical review Actas Esp. Psiquiatr. 42 2014 315 324
38. K. Rasmussen, T. Palmstierna, and S. Levander Differences in psychiatric problems and criminality between individuals treated with central stimulants before and after adulthood J. Atten. Disord. 2015
39. A. Roy, A.J. Oldehinkel, F.C. Verhulst, J. Ormel, and C.A. Hartman Anxiety and disruptive behavior mediate pathways from attention-deficit/hyperactivity disorder to depression J. Clin. Psychiatry 75 2014 e108 e113
40. T.J. Spencer, J. Biederman, and E. Mick Attention-deficit/hyperactivity disorder: diagnosis, lifespan, comorbidities, and neurobiology J. Pediatr. Psychol. 32 2007 631 642
41. E. Staikova, D.J. Marks, C.J. Miller, J.H. Newcorn, and J.M. Halperin Childhood stimulant treatment and teen depression: is there a relationship? J. Child Adolesc. Psychopharmacol. 20 2010 387 393
42. P. Svanborg, G. Thernlund, P.A. Gustafsson, B. Hagglof, A. Schacht, and B. Kadesjo Atomoxetine improves patient and family coping in attention deficit/hyperactivity disorder: a randomized, double-blind, placebo-controlled study in Swedish children and adolescents Eur. Child Adolesc. Psychiatry 18 2009 725 735
43. R. Taurines, J. Schmitt, T. Renner, A.C. Conner, A. Warnke, and M. Romanos Developmental comorbidity in attention-deficit/hyperactivity disorder Atten. Deficit Hyperact. Disord. 2 2010 267 289
44. R. Thomas, S. Sanders, J. Doust, E. Beller, and P. Glasziou Prevalence of attention-deficit/hyperactivity disorder: a systematic review and meta-analysis Pediatrics 135 2015 e994 e1001
45. H. Ushijima, M. Usami, K. Saito, M. Kodaira, and M. Ikeda Time course of the development of depressive mood and oppositional defiant behavior among boys with attention deficit hyperactivity disorder: differences between subtypes Psychiatry Clin. Neurosci. 66 2012 285 291
46. J. Waxmonsky Assessment and treatment of attention deficit hyperactivity disorder in children with comorbid psychiatric illness Curr. Opin. Pediatr. 15 2003 476 482
47. T.E. Wilens Effects of methylphenidate on the catecholaminergic system in attention-deficit/hyperactivity disorder J. Clin. Psychopharmacol. 28 2008 S46 S53
48. J.C. Wolff, and T.H. Ollendick The comorbidity of conduct problems and depression in childhood and adolescence Clin. Child Fam. Psychol. Rev. 9 2006 201 220
49. World Health Organization Collaborating Centre for Drug Statistic Methodology. Guidelines for ATC Classification and DDD Assignment 2014 World Health Organization Oslo, Norway
50. M. Yuce, S.S. Zoroglu, M.F. Ceylan, H. Kandemir, and K. Karabekiroglu Psychiatric comorbidity distribution and diversities in children and adolescents with attention deficit/hyperactivity disorder: a study from Turkey Neuropsychiatr. Dis. Treat. 9 2013 1791 1799
51. G. Zalsman, D.A. Brent, and V.R. Weersing Depressive disorders in childhood and adolescence: an overview: epidemiology, clinical manifestation and risk factors Child Adolesc. Psychiatr. Clin. N. Am. 15 2006 827 841